ropinirole hydrochloride
- Product NDC
- 50268-743
- 11-digit product format
- 502680743
- Labeler code
- 50268
- Product ID
- 50268-743_2b4c1c97-dc70-3801-e063-6394a90a7faf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ropinirole hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA078110
- Marketing category
- ANDA
- Marketing start
- 2022-08-19
- Substance
- ROPINIROLE HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078110-001 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | RS | 2008-05-05 |
| A078110-002 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2008-05-05 | |
| A078110-003 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2008-05-05 | |
| A078110-004 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2008-05-05 | |
| A078110-005 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2008-05-05 | |
| A078110-006 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2008-05-05 | |
| A078110-007 | ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2008-07-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078110-001 | AB |
| A078110-002 | AB |
| A078110-003 | AB |
| A078110-004 | AB |
| A078110-005 | AB |
| A078110-006 | AB |
| A078110-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078110-001 | ROPINIROLE HYDROCHLORIDE | EQ 0.25MG BASE | TABLET / ORAL | AB | RS | 2008-05-05 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078110-002 | ROPINIROLE HYDROCHLORIDE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2008-05-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078110-003 | ROPINIROLE HYDROCHLORIDE | EQ 1MG BASE | TABLET / ORAL | AB | 2008-05-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078110-004 | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE | TABLET / ORAL | AB | 2008-05-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078110-005 | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE | TABLET / ORAL | AB | 2008-05-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078110-006 | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE | TABLET / ORAL | AB | 2008-05-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078110-007 | ROPINIROLE HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2008-07-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078110-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078110-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078110-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078110-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078110-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078110-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078110-007 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | A-S Medication Solutions | a97d5e2d-4a17-4d80-9216-1b0780199502 | 2026-03-23 | Warnings, Adverse reactions | 078110 ANDA078110 |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | Northwind Health Company, LLC | ab6d21b6-2584-4b97-e053-2a95a90adc50 | 2026-01-01 | Warnings, Adverse reactions | 078110 ANDA078110 |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | SOLCO HEALTHCARE US, LLC | 7734ef0b-584f-42dd-a8b5-adbdf4e4df93 | 2025-05-30 | Warnings, Adverse reactions | 078110 ANDA078110 |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | SOLCO HEALTHCARE US, LLC | 5823b3a2-3256-4d94-97b4-ec6b940312f4 | 2025-05-28 | Warnings, Adverse reactions | 078110 ANDA078110 |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | AvPAK | e699a31a-25fc-554b-e053-2a95a90a843a | 2025-01-09 | Warnings, Adverse reactions | 078110 ANDA078110 50268-743 |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | American Health Packaging | 6849b3c0-e36b-4bea-82f2-b33ae3d44c95 | 2025-01-08 | Warnings, Adverse reactions | 078110 ANDA078110 |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | Bryant Ranch Prepack | 6c10444a-48da-469d-bf8f-1e6e0b7e15f8 | 2023-10-30 | Warnings, Adverse reactions | 078110 ANDA078110 |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | Proficient Rx LP | 89e3865c-1fe1-4f29-9606-8830df4bbe53 | 2023-08-01 | Warnings, Adverse reactions | 078110 ANDA078110 |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | A-S Medication Solutions | 9c4dacc6-cebc-4f42-85fc-41083512b290 | 2023-03-01 | Warnings, Adverse reactions | 078110 ANDA078110 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ropinirole hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ROPINIROLE HYDROCHLORIDE | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| D7ZD41RZI9 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e699a31a-25fc-554b-e053-2a95a90a843a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dc920868-8845-b908-7ca8-0dee3e345af5 | Product name | 2 | 20230123 |
| e24bc1b4-1e16-908e-3d09-29da3ca2fb1f | Product name | 2 | 20170517 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50268-743-11 | ropinirole hydrochloride | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 2 | |
| 50268-743-15 | ropinirole hydrochloride | 50 in 1 BOX | TABLET, FILM COATED | 50 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50268-743-11 | EA - Each | 50268-743 | 073aba0c-db2b-4213-8f84-64065c11026a | 1 | 2022-09-12 |
| 50268-743-15 | EA - Each | 50268-743 | 1e18b6aa-1bef-463b-95fc-c3672e8b0177 | 1 | 2022-09-12 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312845 | rOPINIRole HCl 0.25 MG Oral Tablet | PSN | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 312846 | rOPINIRole HCl 0.5 MG Oral Tablet | PSN | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 314208 | rOPINIRole HCl 1 MG Oral Tablet | PSN | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 312847 | rOPINIRole HCl 2 MG Oral Tablet | PSN | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 312845 | ropinirole 0.25 MG Oral Tablet | SCD | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 312846 | ropinirole 0.5 MG Oral Tablet | SCD | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 314208 | ropinirole 1 MG Oral Tablet | SCD | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 312847 | ropinirole 2 MG Oral Tablet | SCD | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 312845 | ropinirole 0.25 MG (as ropinirole hydrochloride) Oral Tablet | SY | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 312846 | ropinirole 0.5 MG (as ropinirole hydrochloride) Oral Tablet | SY | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 314208 | ropinirole 1 MG (as ropinirole hydrochloride) Oral Tablet | SY | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
| 312847 | ropinirole 2 MG (as ropinirole hydrochloride) Oral Tablet | SY | e699a31a-25fc-554b-e053-2a95a90a843a | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50268-743-11 | 50268074311 | 1 in 1 BLISTER PACK | Historical | |||||
| 50268-743-15 | 50268074315 | 50 BLISTER PACK in 1 BOX (50268-743-15) / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-743-11) | 50 blister pack | 2022-08-19 | 0000-00-00 | No | No | Current |